News

Thermo Fisher Scientific has introduced the Applied Biosystems MagMAX Pro HT NoSpin Plasmid MiniPrep Kit to address the ...
VGXI, Inc., a leading contract development and manufacturing organization (CDMO) specializing in plasmid DNA biopharmaceuticals, including for use in gene therapies, DNA vaccines, and RNA medicines, ...
Results further validate PlaCCine as a novel vaccine platform with potential applications in COVID-19 and other infectious diseases with epidemic implications “It is very encouraging to see strong ...
The Business Research Company’s Phosphoramidite Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 15, 2025 /EINPresswire.com/ -- The ...
Researchers found that flight attendants show reduced DNA repair capacity and immune changes after air travel, which may help ...
AGC Biologics, your friendly CDMO expert, today announced a partnership with Quell Therapeutics ("Quell"), a clinical-stage biotechnology company pioneering engineered T-regulatory (Treg) cell ...
One of the greatest transformations in modern medicine arguably began with a corned beef sandwich.It was the late 1960s, and new Department of ...
Poster presentation abstracts are publicly accessible through the ASGCT website ( https://annualmeeting.asgct.org/abstracts ). PackGene will exhibit at booth 1821. For meeting requests or more ...
For PLG's clients, the collaboration opens access to Recipharm's manufacturing infrastructure, including integrated and ...
First Trial Site Initiated for Phase 3 OVATION 3 Study of IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer - On May 8, 2025, the Company announced initiation of the first trial site for the OVATION ...